GlycoNex Licenses SPD8 Biosimilar to Undisclosed Company for Osteoporosis Treatment
Taiwan-based GlycoNex, Inc. (TPEx: 4168) has announced a licensing agreement with an undisclosed company for...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity